Recent Price Movement and Market Comparison
Infinium Pharmachem’s recent performance has been underwhelming when compared to the broader Sensex index. Over the past week, the stock has fallen by 4.98%, while the Sensex gained 0.39%. This negative divergence extends over longer periods as well, with the stock down 4.30% in the last month against a 1.34% rise in the Sensex. Year-to-date, the stock has declined 6.24%, significantly underperforming the benchmark’s 2.14% loss. Over the last year, the stock’s decline of 13.99% contrasts sharply with the Sensex’s robust 11.60% gain, highlighting persistent weakness in Infinium Pharmachem’s share price relative to the broader market.
Technical Indicators Point to Continued Downtrend
Technical analysis f...
Read full news article





